Salvatore Emma Jr.

All filings by Salvatore Emma Jr. on record concern Arrhythmia Research Technology Inc /DE/. In total, 30 filings cover trades dated from 18 August 2014 to 16 December 2016.

Both buying and selling appear: 6 purchases worth €145k, against 19 sales worth €70k. The net balance comes to €75k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants and 1 option exercise. So far in 2016, the count stands at 3 purchases and no sales.

A typical purchase (the median) is worth €5,656. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 6 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 50% of cases, with a median move of +1.3%. This is a record of the past, not a forecast.

The latest filing, published on 20 December 2016, reports an open-market purchase of €4,972 in Arrhythmia Research Technology Inc /DE/. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.